These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32613426)

  • 1. Cefepime is Associated with Acute Encephalopathy in Critically Ill Patients: A Retrospective Case-Control Study.
    Singh TD; O'Horo JC; Day CN; Mandrekar J; Rabinstein AA
    Neurocrit Care; 2020 Dec; 33(3):695-700. PubMed ID: 32613426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
    Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
    Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy.
    Fugate JE; Kalimullah EA; Hocker SE; Clark SL; Wijdicks EF; Rabinstein AA
    Crit Care; 2013 Nov; 17(6):R264. PubMed ID: 24200036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and outcomes of critically ill patients with acute brain failure: A novel end point.
    Singh TD; O'Horo JC; Gajic O; Sakusic A; Day CN; Mandrekar J; Kashyap R; Reddy DRS; Rabinstein AA
    J Crit Care; 2018 Feb; 43():42-47. PubMed ID: 28843663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of acute kidney injury risk associated with vancomycin and concomitant piperacillin/tazobactam or cefepime in the intensive care unit.
    Buckley MS; Hartsock NC; Berry AJ; Bikin DS; Richards EC; Yerondopoulos MJ; Kobic E; Wicks LM; Hammond DA
    J Crit Care; 2018 Dec; 48():32-38. PubMed ID: 30172962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefepime-Induced Neurotoxicity Presenting with Nonconvulsive Status Epilepticus Admitted as a Stroke Alert.
    Cunningham JM; Sachs KV; Allyn R
    Am J Case Rep; 2020 Mar; 21():e921643. PubMed ID: 32147665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of Acute Kidney Injury Among Critically Ill Patients With Brief Empiric Use of Antipseudomonal β-Lactams With Vancomycin.
    Schreier DJ; Kashani KB; Sakhuja A; Mara KC; Tootooni MS; Personett HA; Nelson S; Rule AD; Steckelberg JM; Tande AJ; Barreto EF
    Clin Infect Dis; 2019 Apr; 68(9):1456-1462. PubMed ID: 30165426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical, Electroencephalographic Features and Prognostic Factors of Cefepime-Induced Neurotoxicity: A Retrospective Study.
    Li HT; Lee CH; Wu T; Cheng MY; Tseng WJ; Chang CW; Hsieh HY; Chiang HI; Lin CY; Chang BL; Lin WR; Lim SN
    Neurocrit Care; 2019 Oct; 31(2):329-337. PubMed ID: 30756319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children.
    Joyce EL; Kane-Gill SL; Priyanka P; Fuhrman DY; Kellum JA
    J Am Soc Nephrol; 2019 Nov; 30(11):2243-2251. PubMed ID: 31501354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Cefepime on Neurotoxicity Development in Critically Ill Adults With Renal Dysfunction.
    Khan A; DeMott JM; Varughese C; Hammond DA
    Chest; 2020 Jul; 158(1):157-163. PubMed ID: 32147247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefepime Neurotoxicity in Patients With Normal Renal Function: An Overlooked Cause of Encephalopathy in the Intensive Care Unit.
    Alagha Z; Crow S; Abdeen AMZ; Alastal M; Alastal A
    J Investig Med High Impact Case Rep; 2024; 12():23247096241259534. PubMed ID: 39068595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RIFLE-based data collection/management system applied to a prospective cohort multicenter Italian study on the epidemiology of acute kidney injury in the intensive care unit.
    Garzotto F; Piccinni P; Cruz D; Gramaticopolo S; Dal Santo M; Aneloni G; Kim JC; Rocco M; Alessandri E; Giunta F; Michetti V; Iannuzzi M; Belluomo Anello C; Brienza N; Carlini M; Pelaia P; Gabbanelli V; Ronco C;
    Blood Purif; 2011; 31(1-3):159-71. PubMed ID: 21228585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic/Pharmacodynamic Dosage Individualization of Cefepime in Critically Ill Patients: A Case Study.
    Goutelle S; Jay L; Boidin C; Cohen S; Bourguignon L; Bleyzac N; Wallet F; Vassal O; Friggeri A
    Ther Drug Monit; 2021 Aug; 43(4):451-454. PubMed ID: 33883521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acute kidney injury on weaning from mechanical ventilation in critically ill patients.
    Vieira JM; Castro I; Curvello-Neto A; Demarzo S; Caruso P; Pastore L; Imanishe MH; Abdulkader RC; Deheinzelin D
    Crit Care Med; 2007 Jan; 35(1):184-91. PubMed ID: 17080002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefepime Induced Encephalopathy in a Non-dialysis Dependent Chronic Kidney Disease Patient: A Case Report.
    Muniandy G; Kamaruzaman L; Jan TH; Mohd R; Neesam MT; Fong Voon K; Pau Kiew B; Mustafar R
    Acta Med Indones; 2023 Jan; 55(1):78-82. PubMed ID: 36999269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute kidney injury with combination vancomycin and piperacillin-tazobactam therapy in the ICU: A retrospective cohort study.
    O'Callaghan K; Hay K; Lavana J; McNamara JF
    Int J Antimicrob Agents; 2020 Jul; 56(1):106010. PubMed ID: 32413387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefepime-associated thrombocytopenia in a critically ill patient.
    Lim PP; Chong CP; Aziz NA
    Int J Clin Pharm; 2011 Dec; 33(6):902-4. PubMed ID: 21986835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime.
    Navalkele B; Pogue JM; Karino S; Nishan B; Salim M; Solanki S; Pervaiz A; Tashtoush N; Shaikh H; Koppula S; Koons J; Hussain T; Perry W; Evans R; Martin ET; Mynatt RP; Murray KP; Rybak MJ; Kaye KS
    Clin Infect Dis; 2017 Jan; 64(2):116-123. PubMed ID: 27986669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT).
    Piccinni P; Cruz DN; Gramaticopolo S; Garzotto F; Dal Santo M; Aneloni G; Rocco M; Alessandri E; Giunta F; Michetti V; Iannuzzi M; Belluomo Anello C; Brienza N; Carlini M; Pelaia P; Gabbanelli V; Ronco C;
    Minerva Anestesiol; 2011 Nov; 77(11):1072-83. PubMed ID: 21597441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyschloremia Is a Risk Factor for the Development of Acute Kidney Injury in Critically Ill Patients.
    Shao M; Li G; Sarvottam K; Wang S; Thongprayoon C; Dong Y; Gajic O; Kashani K
    PLoS One; 2016; 11(8):e0160322. PubMed ID: 27490461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.